Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)

INR 24.21

(-0.62%)

Annual Balance Sheets

(In INR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.88 Billion 2.12 Billion 1.03 Billion 1.26 Billion 1.24 Billion 534.02 Million
Total Current Assets 358.02 Million 654.28 Million 339.54 Million 930.2 Million 987.35 Million 381.99 Million
Cash And Short Term Investments 12.85 Million 46.42 Million 12.26 Million 120.98 Million 25.08 Million 146.24 Million
Cash and Cash Equivalents 12.85 Million 46.42 Million 12.26 Million 9.85 Million 4.07 Million 11.97 Million
Short Term Investments 74.51 Million 83.66 Million 93.08 Million 111.13 Million 21 Million 134.27 Million
Net Receivables 156.67 Million 44.43 Million 29.96 Million 176.72 Million 734.35 Million 162.75 Million
Inventory 14.22 Million 362.49 Million 134.9 Million 517.18 Million 144.39 Million 17.21 Million
Other Current Assets 53 Thousand 40 Thousand 31 Thousand 30 Thousand 106 Thousand 311 Thousand
Total Non-Current Assets 1.52 Billion 1.47 Billion 700.31 Million 338.09 Million 262.24 Million 152.03 Million
Net PPE 1.15 Billion 1.15 Billion 361.28 Million 46.84 Million 49.2 Million 51.71 Million
Good Will And Intangible Assets 11.6 Million 12.29 Million -1000.00 14.94 Million 17.96 Million 12.2 Million
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 92.81 Million 90.63 Million 125.16 Million 136.33 Million 94.98 Million 8.77 Million
Tax Assets 266.55 Million 210.26 Million 200.92 Million 139.97 Million 100.08 Million 79.32 Million
Other Non Current Assets 39 Thousand -1000.00 12.94 Million -1000.00 2000.00 2000.00
Other Assets 4000.00 4000.00 1000.00 1000.00 -0.00 -
Total Liabilities 1 Billion 1.07 Billion 699.44 Million 1.06 Billion 942.82 Million 159.07 Million
Total Current Liabilities 940.42 Million 1.01 Billion 640.9 Million 1 Billion 884.75 Million 125.25 Million
Account Payables 10.31 Million 8.69 Million 147.93 Million 435.31 Million 441.84 Million 4.18 Million
Tax Payables - - - - - -
Short Term Debt 702.24 Million 778.85 Million 272.93 Million 30.38 Million 322.22 Million 35.86 Million
Deferred Revenue 200.18 Million 196.89 Million 28.84 Million 381.2 Million 482 Thousand 1.42 Million
Other Current Liabilities 27.67 Million 28.2 Million 191.2 Million 160.17 Million 120.2 Million 83.78 Million
Total Non Current Liabilities 63.9 Million 61.11 Million 58.53 Million 56.48 Million 58.07 Million 33.82 Million
Long-Term Debt - - - - - -
Deferred Revenue Non Current - - - - 4.8 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 63.9 Million 61.11 Million 58.53 Million 56.48 Million 53.27 Million 33.82 Million
Other Liabilities - 0.00 - - - -0.00
Total Equity 882.14 Million 1.05 Billion 340.41 Million 204.73 Million 306.77 Million 374.95 Million
Stock Holders Equity 882.14 Million 1.05 Billion 340.41 Million 204.73 Million 306.77 Million 374.95 Million
Common Stock 431.8 Million 431.8 Million 431.8 Million 431.8 Million 431.8 Million 431.8 Million
Retained Earnings -662.11 Million -495.72 Million -408.18 Million -227.13 Million -115 Million -56.9 Million
Accumulated other comprehensive income 431.8 Million 431.8 Million 431.8 Million 431.8 Million 431.8 Million 431.8 Million
Common Stock Equity 882.14 Million 1.05 Billion 340.41 Million 204.73 Million 306.77 Million 374.95 Million
Capital Lease Obligation - - - - - -
Total Investments 167.32 Million 174.29 Million 218.25 Million 247.46 Million 94.98 Million 8.77 Million
Total Debt 702.24 Million 778.85 Million 272.93 Million 30.38 Million 322.22 Million -
Net Debt 689.39 Million 732.42 Million 260.66 Million 20.53 Million 318.14 Million -11.97 Million

Balance Sheet Charts